Rapidly progressive malignant melanoma in a patient treated with tocilizumab.
Michiel
M
Bonny
Veronique
V
Buyse
Erwin
E
Suys
D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008545:Melanoma / Q000556:secondary*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000473:pathology*
D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab